Daiichi Sankyo starts trial for mRNA vaccine as booster dose in Japan

Daiichi Sankyo has initiated a trial in Japan to investigate a booster dose of DS-5670, an mRNA vaccine against COVID-19...

January 31, 2022 | Monday | News
Japan's Fujifilm buys Atara’s T-cell manufacturing facility for $100 M

Atara Biotherapeutics, Inc. has entered into a long term strategic agreement with FUJIFILM Diosynth Biotechnologies...

January 27, 2022 | Thursday | News
Illumina collaborates with National Cancer Center Japan

Illumina, Inc. and the National Cancer Center Japan have announced an international joint research project that wil...

January 25, 2022 | Tuesday | News
Japan approves VYVGART for treatment of generalised Myasthenia Gravis

Netherlands-based argenx SE has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved ...

January 20, 2022 | Thursday | News
Japan’s Daiichi Sankyo divests certain cardiovascular products, shifting focus to oncology

Japan-based pharmaceutical firm Daiichi Sankyo has entered into an agreement with Cosette Pharmaceuticals, Inc. whereby ...

January 19, 2022 | Wednesday | News
IQVIA releases emerging biotech/biopharma trends to watch for in 2022

IQVIA has come up with the key trends that emerging biotech and emerging biopharma companies should look out for in 2022...

January 19, 2022 | Wednesday | News
Japan approves MicroPort CRM's Alizea Bluetooth Pacemaker

MicroPort CRM, a pioneering company in the field of Cardiac Rhythm Management, headquartered in France, has recentl...

January 17, 2022 | Monday | News
Japan’s Takeda buys Adaptate Biotherapeutics to strengthen immuno-oncology portfolio

Takeda Pharmaceutical Company has announced the exercise of its option to acquire Adaptate Biotherapeutics, a UK-based c...

January 11, 2022 | Tuesday | News
Japan develops cancer therapy using on-site synthesis of anti-cancer drugs

An international research group at the RIKEN Cluster for Pioneering Research (CPR) in Japan has successfully treated can...

January 10, 2022 | Monday | News
Japan’s Otsuka Pharma invests in development of psychedelic medicines

The McQuade Center for Strategic Research and Development, LLC (MSRD), established in the US by Japan-based Otsuka Pharm...

January 7, 2022 | Friday | News
Japan's Shimadzu enters into 'smart cells' field with new investment

Japan-based Shimadzu Corporation has invested in Bacchus Bio innovation, a startup company spun off from Kobe University...

January 6, 2022 | Thursday | News
Japan's PRISM BioLab partners with Roche and Genentech for drug discovery research

PRISM BioLab, a Japan based biotechnology company with a proprietary peptide mimetic small molecule drug discovery ...

January 5, 2022 | Wednesday | News
Japan opts for drug repurposing to stop dementia

Via drug repositioning, a team of scientists at the Osaka City University in Japan has created a combination of rifampic...

January 1, 2022 | Saturday | News
Japan-funded study explores antibodies to neutralise omicron

An international team of scientists have identified antibodies that neutralize omicron and other SARS-CoV-2 variants. Th...

December 28, 2021 | Tuesday | News
Merck and Ridgeback’s COVID-19 pill receives ‘special approval’ in Japan

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics have announced that Japan’...

December 27, 2021 | Monday | News
Eisai to market Gilead’s rheumatoid arthritis drug in Asia

Japanese firm Eisai has entered into an agreement with Gilead Sciences, Inc. for the commercialisation and distribution ...

December 23, 2021 | Thursday | News
Japan approves booster shot for Moderna COVID-19 vaccine

US-based Brand Institute has announced its successful partnership with Moderna in naming their mRNA COVID-19 vaccine: SP...

December 20, 2021 | Monday | News
Japan’s NEC teams up with BostonGene to improve cancer care

US-based BostonGene Corporation and Japanese firm NEC Corporation have announced a strategic global partnershi...

December 16, 2021 | Thursday | News